The Italian Data Protection Authority (“Garante per la Protezione dei Dati Personali”) published a provision in which it established that some services for e-mail management are configured to collect and store metadata...more
The Italian Data Protection Authority (Garante per la protezione dei dati personali) has launched a public consultation on webscraping.
On 22 November 2023, the Italian Data Protection Authority (Garante per la protezione...more
The NIS 2 Directive ("Directive" or "NIS2") has been approved by the Council. The Directive will be published in the Official Journal of the European Union in the coming days and will enter into force on the twentieth day...more
The General Data Protection Regulation 2016/679 (GDPR) provides means to enforce provisions related to personal data processing by you as a data controller or data processor. It introduces collective actions everywhere in...more
The General Data Protection Regulation 2016/679 (GDPR) provides means to enforce provisions related to personal data processing by you as a data controller or data processor. It introduces collective actions everywhere in...more
11/22/2019
/ Burden of Proof ,
Class Action ,
Cybersecurity ,
Data Breach ,
Data Processors ,
Data Protection ,
EU ,
EU Data Protection Laws ,
European Commission ,
Evidence ,
Forum Shopping ,
General Data Protection Regulation (GDPR) ,
International Data Transfers ,
Litigation Strategies ,
Personal Data ,
Personally Identifiable Information ,
Private Right of Action ,
Risk Management ,
Russia
On 4 September, the Legislative Decree no. 101 of 10 August 2018 (the “Decree”) for the national implementation of General Data Protection Regulation (EU) 2016/679 (the “GDPR”) has been published in the Official Journal. ...more
9/14/2018
/ Cybersecurity ,
Data Breach ,
Data Processors ,
Data Protection ,
EU ,
EU Data Protection Laws ,
General Data Protection Regulation (GDPR) ,
International Data Transfers ,
Personal Data ,
Personally Identifiable Information ,
Popular ,
Risk Management
Innovation in the life sciences and health care industries is occurring at a dizzying pace. Five years ago, anti-PD-1 antibodies from Merck and BMS had yet to be approved, CAR-T therapies were still in small-scale clinical...more
4/4/2018
/ 3D Printing ,
Acquisitions ,
Artificial Intelligence ,
Biologics ,
Biosimilars ,
Biotechnology ,
Blockchain ,
Cyber Attacks ,
Cybersecurity ,
Data Breach ,
Digital Health ,
Distributed Ledger Technology (DLT) ,
Drug Pricing ,
Emerging Markets ,
EU ,
General Data Protection Regulation (GDPR) ,
Generic Drugs ,
Innovation ,
Life Sciences ,
Medical Reimbursement ,
Mergers ,
Over The Counter Derivatives (OTC) ,
Pharmaceutical Industry ,
Prescription Drugs ,
Private Equity ,
Regulatory Oversight ,
Supply Chain ,
Transfer Pricing ,
UK Brexit ,
Yates Memorandum